No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Primary Carnitine Deficiency Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. It is composed of drugs used to treat primary carnitine deficiency, a rare genetic disorder that affects the body's ability to produce carnitine, an amino acid that helps the body turn fat into energy. These drugs are used to replace the missing carnitine and help the body use fat for energy. Common drugs used to treat primary carnitine deficiency include L-carnitine, propionyl-L-carnitine, and acetyl-L-carnitine.
Some companies in the Primary Carnitine Deficiency Drug market include AbbVie, Inc., Amneal Pharmaceuticals, Inc., and Mylan N.V. Show Less Read more
